Eksigent, a developer of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, announces a new distribution agreement with New Zealand Scientific
The agreement covers sales and service of Eksigent's NanoLC HPLC product line in New Zealand and Australia.
Auckland based New Zealand Scientific provides sales and service of advanced instruments for life science and analytical laboratories.
The company's top management has over 20 years of experience in the laboratory instrument market.
New Zealand Scientific serves the Australian market through its partner company, Australasian Analytical Systems of Brisbane.
"We are excited to extend our reach 'down under,' where opportunities for delivering proteomic research tools are growing," commented David Weber, Eksigent's president and CEO.
"New Zealand Scientific is well-positioned to sell our NanoLC line to proteomics researchers in those countries".
"We are committed to offering quality brands to our customers and are pleased to add the innovative Eksigent NanoLC products to our portfolio," stated Laurence Van Dam, founder and president of New Zealand Scientific.
"We pride ourselves on our ability to help solve analytical problems and we see the NanoLC as a powerful tool for scientists".
Eksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low-flow fluid delivery solutions.
The company combines proprietary microfluidic pumping technology with creative approaches that help customers improve productivity and expand their research and market opportunities.
